drugset / Trial / NCT01435200
Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy
RandomizedParallel-groupOpen-labelTreatment
Summary
Can intravenous iron lower the rate of blood transfusion in gynecologic cancer patients receiving platinum based chemotherapy than oral iron?
Timeline
- Start
- 2011-06
- Primary completion
- 2012-10
- Completion
- 2012-11
Outcome
Met primary endpoint
paper Nine patients (28.1%) in the study group and 18 patients (56.3%) in the control group required blood transfusion through 6 cycles of chemotherapy (p=0.02). PMID 24099839 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron sucrose | Unknown | 200 mg | Intravenous |